Concepedia

Maria Mancini

MM

Statistics

Publications

10

Citations

366

H-Index

10

Active since

2000

Affiliations

Catabasis Pharmaceuticals (United States)(Current)

University of Florida Health

University of Modena and Reggio Emilia

Istituti di Ricovero e Cura a Carattere Scientifico

Fondazione IRCCS Istituto Nazionale dei Tumori

Maria Mancini is an author at Catabasis Pharmaceuticals (United States) specializing in medicine, pharmacology, and muscular dystrophy.

Publications per year

2000–2021

10

Publications

10

Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis

Maria Mancini, Aleksandra Terzic, Barbara A. Conley et al. · Developmental Dynamics · 2009 · 67 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +11

Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry

Leslie Cowen, Maria Mancini, Ann Martin et al. · BMC Neurology · 2019 · 52 citations · Full text

Medicine, Pharmacotherapy, Drug Utilization Review +10

Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF- <i>κ</i> B Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy

Erika Finanger, Krista Vandenborne, Richard S. Finkel et al. · Journal of Neuromuscular Diseases · 2018 · 48 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

Giuseppe Procopio, Michele Prisciandaro, Roberto Iacovelli et al. · Clinical Genitourinary Cancer · 2018 · 40 citations

Medicine, Oncology, Pharmacology +10

Rostral ventrolateral medulla opioid receptor activation modulates glutamate release and attenuates the exercise pressor reflex

Takeshi Ishide, Maria Mancini, Timothy J. Maher et al. · Brain Research · 2000 · 31 citations

Life Sciences, Neurobiology, Neuroscience +14

1–5 of 10